Sign in / Join Now
ETFs & Funds
Ligand Pharmaceuticals: 2014 Run Not Done With Short And Long Term Catalysts Coming $
Add a reply...
Latest StockTalks »
people get LGND breaking news and analysis by email alert.
Get email alerts on LGND »
Ligand Pharmaceuticals Incorporated
Get latest price
From other sites
Ligand Partner Lundbeck Receives FDA Approval Of Carnexiv™ (carbamazepine) Injection As Intravenous Short-Term Replacement Therapy For Certain Seizure Types
at TheStreet (Oct 7, 2016)
Ligand Pharmaceuticals Enters Oversold Territory (LGND)
at Nasdaq.com (Sep 27, 2016)
Ligand Licenses Four Programs To Seelos Therapeutics
at TheStreet (Sep 22, 2016)
Ligand Enters OmniAb® License Agreement With TeneoBio, Inc.
at TheStreet (Sep 16, 2016)
Commit To Purchase Ligand Pharmaceuticals At $100, Earn 10.8% Annualized Using Options
at Nasdaq.com (Sep 15, 2016)